Newron Pharmaceuticals
NWRN.SW
#8334
Rank
A$0.27 B
Marketcap
$13.48
Share price
-0.70%
Change (1 day)
5.29%
Change (1 year)

EPS for Newron Pharmaceuticals (NWRN.SW)

EPS in 2023: -$1.70

According to Newron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.70. In 2023 the company made an earnings per share (EPS) of -$1.70 a decrease over its 2022 EPS that were of -$1.66.

EPS history for Newron Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023-$1.702.03%
2022-$1.6615.39%
2021-$1.44-31.32%
2020-$2.1014.74%
2019-$1.8336.6%
2018-$1.34159.87%
2017-$0.51-67.81%
2016-$1.60-39.24%
2015-$2.63107.61%
2014-$1.2715.8%
2013-$1.09119.91%
2012-$0.50-66.51%
2011-$1.49-71.49%
2010-$5.21-10.83%
2009-$5.8542.06%
2008-$4.1256.53%
2007-$2.63-52.84%
2006-$5.58-188.53%
2005$6.30